# Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK

> **NCT05587231** · PHASE4 · UNKNOWN · sponsor: **Navy Medical Center San Diego** · enrollment: 60 (estimated)

## Conditions studied

- Steroid Ophthalmic Insert

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert
- **DRUG:** Topical Fluorometholone

## Key facts

- **NCT ID:** NCT05587231
- **Lead sponsor:** Navy Medical Center San Diego
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587231, "Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05587231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*